综合分析和实验证实,ADRM1在KIRC中起着致癌和免疫抑制的作用
Likun Li1, Limin Wang2, Dongxia Cao1
1Department of Urology Surgery, Air Force Hospital of Eastern Theater Command, The Chinese People's Liberation Army, Nanjing, Jiangsu, China.
Biochemical and biophysical research communications
|December 17, 2025
概括
粘附调节分子1 (ADRM1) 通过ERK通路促进脏清细胞癌 (KIRC) 的扩散. 上调的ADRM1表达与预后不佳有关,这表明它是KIRC的潜在治疗标.
科学领域:
- 在瘤学瘤学.
- 分子生物学分子生物学
- 遗传学 是一个遗传学.
背景情况:
- 脏清细胞癌 (KIRC) 是一种主要的癌症类型,具有具有挑战性的进展和不良预后.
- 粘附调节分子1 (ADRM1) 在KIRC发展中的作用尚不清楚.
研究的目的:
- 研究KIRC.中的ADRM1的表达,功能和预后价值.
- 在KIRC.中探索涉及ADRM1的调控机制和信号通路.
主要方法:
- 对ADRM1表达和生存相关性的TCGA和CPTAC数据集的分析.
- 在体外功能测试 (qPCR,西部斑点,增殖测试) 和 luciferase 记者基因测试.
- 检查免疫透和分子通路 (GSEA,ERK通路分析).
主要成果:
- 在KIRC中ADRM1显著上调,并与晚期和不良预后相关.
- 过度表达ADRM1促进KIRC细胞的增殖,由CTCF通过ERK通路调节.
- ADRM1与免疫检查点基因相关,并影响Treg细胞.
结论:
- 由CTCF监管的ADRM1通过ERK路径促进KIRC的扩散.
- ADRM1作为预后生物标志物和KIRC的潜在治疗标.
相关概念视频
Abnormal Proliferation
5.1K
Under normal conditions, most adult cells remain in a non-proliferative state unless stimulated by internal or external factors to replace lost cells. Abnormal cell proliferation is a condition in which the cell's growth exceeds and is uncoordinated with normal cells. In such situations, cell division persists in the same excessive manner even after cessation of the stimuli, leading to persistent tumors. The tumor arises from the damaged cells that replicate to pass the damage to the...
5.1K
mTOR Signaling and Cancer Progression
4.6K
The mammalian target of rapamycin or mTOR protein was discovered in 1994 due to its direct interaction with rapamycin. The protein gets its name from a yeast homolog called TOR. The mTOR protein complex in mammalian cells plays a major role in balancing anabolic processes such as the synthesis of proteins, lipids, and nucleotides and catabolic processes, such as autophagy in response to environmental cues, such as availability of nutrients and growth factors.
The mTOR pathway or the...
The mTOR pathway or the...
4.6K


